The peptidases from fungi and viruses

Biological Chemistry

Volumn 387, Issue 8, 2006, Pages 1023-1029

  James, Michael N G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Active site; Catalytic mechanism; Catalytic triad; G1 peptidase; Hepatitis A virus 3C peptidase; Scytalidoglutamic peptidase

Indexed keywords

BETA LACTONE; CAPSID PROTEIN; CHYMOTRYPSIN; CYSTEINE SULFUR; FUNGAL ENZYME; GLUTAMIC ACID; GLUTAMINE; HEPATITIS A VIRUS 3C PEPTIDASE; HISTIDINE; PEPTIDASE; SCYTALIDOGLUTAMIC PEPTIDASE; SERINE OXYGEN; SERINE PEPTIDASE; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS PROTEIN; WATER;

ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME CONFORMATION; ENZYME MECHANISM; ENZYME MODIFICATION; EXTRACELLULAR SPACE; FUNGUS; FUNGUS CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; SCYTALIDIUM LIGNICOLUM; SHORT SURVEY; THREE DIMENSIONAL IMAGING; VIRUS MORPHOLOGY;

ASCOMYCOTA; BINDING SITES; CATALYSIS; CRYSTALLOGRAPHY, X-RAY; ENZYME ACTIVATION; HEPATITIS A VIRUS; PEPTIDE HYDROLASES; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY;

FUNGI; HEPATITIS A VIRUS; MIRIDAE; SCYTALIDIUM LIGNICOLA;

EID: 33746926428     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.126     Document Type: Short Survey

References (28)

1. Allaire, M., Chernaia, M.M., Malcolm, B.A., and James, M.N. (1994). Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases. Nature 369, 72-76.
2. Andino, R., Rieckhof, G.E., Trono, D., and Baltimore, D. (1990). Substitutions in the protease (3Cpro) gene of poliovirus can suppress a mutation in the 5′ non-coding region. J. Virol. 64, 607-612.
3. Bergmann, E.M. and James, M.N.G. (2000). The 3C proteinases of picornaviruses and other positive-sense, single-stranded RNA viruses. In: Handbook of Experimental Pharmacology, vol. 140, K. von der Helm, B. Korant and J.C. Cheronis, eds. (Heidelberg, Germany: Springer), pp. 117-143.
4. Bergmann, E.M., Mosimann, S.C., Chernaia, M.M., Malcolm, B.A., and James, M.N. (1997). The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition. J. Virol. 71, 2436-2448.
5. Bergmann, E.M., Cherney, M.M., McKendrick, J., Frormann, S., Luo, C., Malcolm, B.A., Vederas, J.C., and James, M.N. (1999). Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV. Virology 267, 153-163.
6. Betzel, C., Pal, G.P., and Saenger, W. (1988). Three-dimensional structure of proteinase K at 0.15 nm resolution. Eur. J. Biochem. 178, 155-171.
7. Birtley, J.R., Knox, S.R., Jaulent, A.M., Brick, P., Leatherbarrow, R.J., and Curry, S. (2005). Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity. J. Biol. Chem. 280, 11520-11527.
8. Dragovich, P.S., Webber, S.E., Babine, R.E., Fuhrman, S.A., Patick, A.K., Matthews, D.A., et al. (1998). Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies. J. Med. Chem. 41, 2819-2834.
9. Fujinaga, M., Cherney, M.M., Oyama, H., Oda, K., and James, M.N.G. (2004). The molecular structure and catalytic mechanism of a novel carboxyl peptidase from Scytalidium lignicolum. Proc. Natl. Acad. Sci. USA 101, 3364-3369.
10. Gamarnik, A.V., and Andino, R. (2000). Interactions of viral protein 3CD and poly(rC) binding protein with the 5′ untranslated region of the poliovirus genome. J. Virol. 74, 2219-2226.
11. Gerber, K., Wimmer, E., and Paul, A.V. (2001). Biochemical and genetic studies of the initiation of human rhinovirus 2 RNA replication: purification and enzymatic analysis of the RNA-dependent RNA polymerase 3D(pol). J. Virol. 75, 10969-10978.
12. James, M.N.G. (2004). Catalytic pathways of aspartic peptidases. In: Handbook of Proteolytic Enzymes, 2nd edition, A.J. Barrett, N.D. Rawlings, and J.F. Woessner, eds. (London, UK: Elsevier Ltd.), pp. 12-19.
13. James, M.N.G. and Sielecki, A.R. (1983). Structure and refinement of penicillopepsin at 1.8 Å resolution. J. Mol. Biol. 163, 299-361.
14. James, M.N.G., Sielecki, A.R., Salituro, F., Rich, D.H., and Hofmann, T. (1982). Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin. Proc. Natl. Acad. Sci. USA 79, 6137-6141.
15. James, M.N.G., Sielecki, A.R., Hayakawa, K., and Gelb, M.H. (1997). Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides. Biochemistry 31, 3872-3886.
16. Kataoka, Y., Takada, K., Oyama, H., Tsumani, M., James, M.N.G., and Oda, K. (2005). Catalytic residues and substrate specificity of scytalidoglutamic peptidase, the first member of the eqolisin family (G1) of peptidases. FEBS Lett. 579, 2991-2994.
17. Lall, M.S., Karvellas, C., and Vederas, J.C. (1999). β-Lactones as a new class of cysteine proteinase inhibitors: inhibition of hepatitis A virus 3C proteinase by N-Cbz-serine β-lactone. Org. Lett. 1, 803-806.
18. Lall, M.S., Ramtohul, Y.K., James, M.N., and Vederas, J.C. (2002). Serine and threonine β-lactones: a new class of hepatitis A virus 3C cysteine proteinase inhibitors. J. Org. Chem. 67, 1536-1547.
19. Lee, T.-W., Cherney, M.M., Huitema, C., Liu, J., James, K.E., Powers, J.C., Eltis, L.D., and James, M.N.G. (2005). Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like Aza-peptide epoxide. J. Mol. Biol. 353, 1137-1151.
20. Mosimann, S.C., Cherney, M.M., Sia, S., Plotch, S., and James, M.N. (1997). Refined X-ray crystallographic structure of the poliovirus 3C gene product. J. Mol. Biol. 273, 1032-1047.
21. Murao, S., Oda, K., and Matsushita, Y. (1972). New acid proteases from Scytalidium lignicolum M-133. Agric. Biol. Chem. 37, 1417-1421.
22. Oda, K. and Murao, S. (1991). Pepstatin-insensitive carboxyl proteinases. In: Structure and Function of the Aspartic Proteinases: Genetics, Structures, and Mechanisms, B.M. Dunn, ed. (New York, USA: Plenum Press), pp. 185-201.
23. Rawlings, N.D., Tolle, D.P., and Barrett, A.J. (2004). MEROPS: the peptidase database. Nucleic Acids Res. 32, D160-D164.
24. Rossmann, M.G. (1972). The Molecular Replacement Method (New York, USA: Gordon and Breach).
25. Wlodawer, A. and Erickson, J.W. (1993). Structure based inhibitors of HIV-1 protease. Annu. Rev. Biochem. 62, 543-585.
26. Yang, Y., Rijnbrand, R., Watowich, S., and Lemon, S.M. (2004). Genetic evidence for an interaction between a picornaviral cis-acting RNA replication element and 3CD protein. J. Biol. Chem. 279, 12659-12667.
27. Yin, J., Paul, A.V., Wimmer, E., and Rieder, E. (2003). Functional dissection of a poliovirus cis-acting replication element [PV-cre(2C)]: analysis of single- and dual-cre viral genomes and proteins that bind specifically to PV-cre RNA. J. Virol. 77, 5152-5166.
28. Yin, J., Bergmann, E.M., Cherney, M.M., Lall, M.S., Jain, R.P., Vederas, J.C., and James, M.N.G. (2005). Dual modes of modification of hepatitis A virus 3C protease by a serine-derived β-lactone - selective crystallization and formation of a functional catalytic triad in the active site. J. Mol. Biol. 354, 854-871.